These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21684584)

  • 1. Differential expression patterns of CXCR3 variants and corresponding CXC chemokines in clear cell ovarian cancers and endometriosis.
    Furuya M; Yoneyama T; Miyagi E; Tanaka R; Nagahama K; Miyagi Y; Nagashima Y; Hirahara F; Inayama Y; Aoki I
    Gynecol Oncol; 2011 Sep; 122(3):648-55. PubMed ID: 21684584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis.
    Furuya M; Suyama T; Usui H; Kasuya Y; Nishiyama M; Tanaka N; Ishiwata I; Nagai Y; Shozu M; Kimura S
    Hum Pathol; 2007 Nov; 38(11):1676-87. PubMed ID: 17707463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired CXCL4 expression in tumor-associated macrophages (TAMs) of ovarian cancers arising in endometriosis.
    Furuya M; Tanaka R; Miyagi E; Kami D; Nagahama K; Miyagi Y; Nagashima Y; Hirahara F; Inayama Y; Aoki I
    Cancer Biol Ther; 2012 Jun; 13(8):671-80. PubMed ID: 22555803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
    Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
    Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production.
    Romagnani P; Maggi L; Mazzinghi B; Cosmi L; Lasagni L; Liotta F; Lazzeri E; Angeli R; Rotondi M; Filì L; Parronchi P; Serio M; Maggi E; Romagnani S; Annunziato F
    J Allergy Clin Immunol; 2005 Dec; 116(6):1372-9. PubMed ID: 16337473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CXCL4 in microglia in vitro and in vivo and its possible signaling through CXCR3.
    de Jong EK; de Haas AH; Brouwer N; van Weering HR; Hensens M; Bechmann I; Pratley P; Wesseling E; Boddeke HW; Biber K
    J Neurochem; 2008 Jun; 105(5):1726-36. PubMed ID: 18248618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of interferon-gamma- inducible protein-10 and its receptor CXCR3 in chronic pancreatitis.
    Singh L; Bakshi DK; Majumdar S; Vasishta RK; Arora SK; Wig JD
    Pancreatology; 2007; 7(5-6):479-90. PubMed ID: 17912012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of CXCR3 and atypical variant expression and signalling in human T lymphocytes.
    Korniejewska A; Watson M; Ward S
    Methods Mol Biol; 2010; 616():125-47. PubMed ID: 20379873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXC Chemokine Receptor 3 Alternative Splice Variants Selectively Activate Different Signaling Pathways.
    Berchiche YA; Sakmar TP
    Mol Pharmacol; 2016 Oct; 90(4):483-95. PubMed ID: 27512119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR3-B expression correlates with tumor necrosis extension in renal cell carcinoma.
    Gacci M; Serni S; Lapini A; Vittori G; Alessandrini M; Nesi G; Palli D; Carini M
    J Urol; 2009 Feb; 181(2):843-8. PubMed ID: 19095263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro.
    Helbig KJ; Ruszkiewicz A; Lanford RE; Berzsenyi MD; Harley HA; McColl SR; Beard MR
    J Virol; 2009 Jan; 83(2):836-46. PubMed ID: 18987152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
    Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum levels of the CXCR3 chemokine ITAC are associated with the development of transplant coronary artery disease.
    Kao J; Kobashigawa J; Fishbein MC; MacLellan WR; Burdick MD; Belperio JA; Strieter RM
    Circulation; 2003 Apr; 107(15):1958-61. PubMed ID: 12695288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist.
    Heise CE; Pahuja A; Hudson SC; Mistry MS; Putnam AL; Gross MM; Gottlieb PA; Wade WS; Kiankarimi M; Schwarz D; Crowe P; Zlotnik A; Alleva DG
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1263-71. PubMed ID: 15761110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR3 ligands in disease and therapy.
    Van Raemdonck K; Van den Steen PE; Liekens S; Van Damme J; Struyf S
    Cytokine Growth Factor Rev; 2015 Jun; 26(3):311-27. PubMed ID: 25498524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes.
    Korniejewska A; McKnight AJ; Johnson Z; Watson ML; Ward SG
    Immunology; 2011 Apr; 132(4):503-15. PubMed ID: 21255008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Analysis of CXCR3 Splicing Variants and Their Ligands Using NanoBiT-Based Molecular Interaction Assays.
    Nguyen HT; Hurh S; Nguyen LP; Nguyen TU; Park HK; Seong JY; Lee CS; Ham BJ; Hwang JI
    Mol Cells; 2023 May; 46(5):281-297. PubMed ID: 36799104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparate roles of CXCR3A and CXCR3B in regulating progressive properties of colorectal cancer cells.
    Li H; Rong S; Chen C; Fan Y; Chen T; Wang Y; Chen D; Yang C; Yang J
    Mol Carcinog; 2019 Feb; 58(2):171-184. PubMed ID: 30302818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis.
    Segerer S; Banas B; Wörnle M; Schmid H; Cohen CD; Kretzler M; Mack M; Kiss E; Nelson PJ; Schlöndorff D; Gröne HJ
    Am J Pathol; 2004 Feb; 164(2):635-49. PubMed ID: 14742268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neem leaf glycoprotein restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by maintaining CXCR3/CXCL10 balance.
    Chakraborty K; Bose A; Pal S; Sarkar K; Goswami S; Ghosh D; Laskar S; Chattopadhyay U; Baral R
    Int Immunopharmacol; 2008 Feb; 8(2):330-40. PubMed ID: 18182249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.